SEC Form 4 · accession 0001627223-17-000057
Chemours Co · CC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Shelton
Officer — SVP, GC & Corp. Secretary
Period of report
Oct 13, 2017
Accepted (ET)
Oct 13, 2017 · 9:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001627223
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 13, 2017 | M | 5,908 | $15.49 | A | 47,356 | D | |
| Common StockF2,F3 | Oct 13, 2017 | S | 5,908 | $56.01 | D | 41,448 | D | |
| Common Stock | holding | — | — | — | 492 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.49 | Oct 13, 2017 | M | 5,908 | D | Feb 5, 2017 | Feb 4, 2021 | Common Stock | 5,908 | 0 | D |
Explanation of responses
- F1The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2017.
- F2Shares were sold in multiple transactions at prices ranging from $56.00 to $56.04.
- F3Includes directly owned shares, unvested restricted stock units and dividend equivalent units.